» Articles » PMID: 30217198

Lipid Nanoparticles Loading Triptolide for Transdermal Delivery: Mechanisms of Penetration Enhancement and Transport Properties

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2018 Sep 16
PMID 30217198
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In recent years, nanoparticles (NPs) including nanostructured lipid carries (NLC) and solid lipid nanoparticles (SLN) captured an increasing amount of attention in the field of transdermal drug delivery system. However, the mechanisms of penetration enhancement and transdermal transport properties of NPs are not fully understood. Therefore, this work applied different platforms to evaluate the interactions between skin and NPs loading triptolide (TPL, TPL-NLC and TPL-SLN). Besides, NPs labeled with fluorescence probe were tracked after administration to investigate the dynamic penetration process in skin and skin cells. In addition, ELISA assay was applied to verify the in vitro anti-inflammatory effect of TPL-NPs.

Results: Compared with the control group, TPL-NPs could disorder skin structure, increase keratin enthalpy and reduce the SC infrared absorption peak area. Besides, the work found that NPs labeled with fluorescence probe accumulated in hair follicles and distributed throughout the skin after 1 h of administration and were taken into HaCaT cells cytoplasm by transcytosis. Additionally, TPL-NLC could effectively inhibit the expression of IL-4, IL-6, IL-8, IFN-γ, and MCP-1 in HaCaT cells, while TPL-SLN and TPL solution can only inhibit the expression of IL-6.

Conclusions: TPL-NLC and TPL-SLN could penetrate into skin in a time-dependent manner and the penetration is done by changing the structure, thermodynamic properties and components of the SC. Furthermore, the significant anti-inflammatory effect of TPL-NPs indicated that nanoparticles containing NLC and SLN could serve as safe prospective agents for transdermal drug delivery system.

Citing Articles

Emerging role of exosomes in cancer therapy: progress and challenges.

Li J, Wang J, Chen Z Mol Cancer. 2025; 24(1):13.

PMID: 39806451 PMC: 11727182. DOI: 10.1186/s12943-024-02215-4.


Nanoemulsion-based transdermal delivery of third-generation steroidal and non-steroidal aromatase inhibitors in preclinical models.

Gao L, Gao L, Huang S, Sun L, Li M, Shen C Cell Prolif. 2024; 58(3):e13753.

PMID: 39343994 PMC: 11882749. DOI: 10.1111/cpr.13753.


Flexible surface acoustic wave technology for enhancing transdermal drug delivery.

Zhang J, Bahar D, Ong H, Arnold P, Zhang M, Jiang Y Drug Deliv Transl Res. 2024; 15(4):1363-1375.

PMID: 39107672 PMC: 11870993. DOI: 10.1007/s13346-024-01682-y.


Gel-Dispersed Nanostructured Lipid Carriers Loading Thymol Designed for Dermal Pathologies.

Folle C, Marques A, Diaz-Garrido N, Carvajal-Vidal P, Lopez E, Suner-Carbo J Int J Nanomedicine. 2024; 19:1225-1248.

PMID: 38348173 PMC: 10859765. DOI: 10.2147/IJN.S433686.


Freeze-Dried Camelina Lipid Droplets Loaded with Human Basic Fibroblast Growth Factor-2 Formulation for Transdermal Delivery: Breaking through the Cuticle Barrier to Accelerate Deep Second-Degree Burn Healing.

Gao H, Wang X, Wu H, Zhang Y, Zhang W, Wang Z Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895963 PMC: 10610516. DOI: 10.3390/ph16101492.


References
1.
Zhuang C, Li N, Wang M, Zhang X, Pan W, Peng J . Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm. 2010; 394(1-2):179-85. DOI: 10.1016/j.ijpharm.2010.05.005. View

2.
Marjukka Suhonen T, Bouwstra J, Urtti A . Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J Control Release. 1999; 59(2):149-61. DOI: 10.1016/s0168-3659(98)00187-4. View

3.
Lv Q, Yu A, Xi Y, Li H, Song Z, Cui J . Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int J Pharm. 2009; 372(1-2):191-8. DOI: 10.1016/j.ijpharm.2009.01.014. View

4.
Southwell D, Barry B . Penetration enhancers for human skin: mode of action of 2-pyrrolidone and dimethylformamide on partition and diffusion of model compounds water, n-alcohols, and caffeine. J Invest Dermatol. 1983; 80(6):507-14. DOI: 10.1111/1523-1747.ep12535090. View

5.
Zhao Z, Ukidve A, Dasgupta A, Mitragotri S . Transdermal immunomodulation: Principles, advances and perspectives. Adv Drug Deliv Rev. 2018; 127:3-19. DOI: 10.1016/j.addr.2018.03.010. View